Characterization of the 5′ noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment
✍ Scribed by Takahide Nakazawa; Nobuyuki Kato; Showgo Ohkoshi; Akitaka Shibuya; Kunitada Shimotohno
- Book ID
- 118566298
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 540 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Interferon ␣ (IFN ␣) can suppress the replication of hepatitis C virus (HCV) in chronically infected patients. However, HCV persists in a significant number of patients despite the normalization of alanine transaminase (ALT) during IFN ␣ therapy. In this study, HCV variants in patients under IFN ␣ t
In a retrospective study, antibody to hepatitis C virus (anti-HCV antibody) was measured in 80 patients with acute viral hepatitis (type A, 18; type B, 21; type non-A,non-B, 41). Anti-HCV antibody was found in 12 of 20 patients (60%) with non-A,non-B post-transfusion hepatitis (NANB-PTH) and in 9 of